ID   IMC-118
AC   CVCL_B6ZB
DR   Wikidata; Q111733511
RX   Patent=CN113980904A;
RX   PubMed=35429113;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C2021285.
CC   Characteristics: Luminal type B inflammatory and ERBB2+ (Patent=CN113980904A; PubMed=35429113).
CC   Doubling time: 50.31 hours (Patent=CN113980904A; PubMed=35429113).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: Beagle.
DI   NCIt; C124249; Canine mammary carcinoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Female
AG   9Y
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 29-06-23; Version: 5
//
RX   Patent=CN113980904A;
RA   Qiu C.-W., Gao H.-B., Zhou H., Zhang T., Zhou N., He L.-X.,
RA   Wang X.-W., Chen S.-Y., Li J.-H.;
RT   "Canine inflammatory breast cancer cell line and application thereof.";
RL   Patent number CN113980904A, 28-Jan-2022.
//
RX   PubMed=35429113; DOI=10.1111/vco.12822;
RA   Gao H.-B., Zhou H., Gao Y.-M., He L.-X., Li W.-X., Xu M.-X., Feng H.-L.,
RA   Feng X.-J., Qiu C.-W.;
RT   "Establishment of a new cell line of canine inflammatory mammary
RT   cancer: IMC-118.";
RL   Vet. Comp. Oncol. 20:679-687(2022).
//